Tadepalli Karuna
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tadepalli Karuna has a total of 230 co-authors. Here are the top co-authors by number of shared publications:
Sagar Khadanga
Department of Medicine All India Institute of Medical Sciences Bhopal India
5 shared publications- Anjali Shetty
Microbiology Section, Department of Laboratory Medicine, P.D. Hinduja National Hospital and Medical Research Centre, Mumbai, India
4 shared publications - Gagandeep Singh
Department of Microbiology, All India Institute of Medical Sciences , New Delhi
4 shared publications - Immaculata Xess
Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India
4 shared publications - Jayanthi Savio
St John’s Medical College Hospital
4 shared publications - Khangembam Jitenkumar Singh
Data Centre, Indian Council of Medical Research, New Delhi, India
4 shared publications
Latest Publications
- Open Access
- 23 March 2026
- Published by Springer Nature in Cureus
- Vol. 18 (3)
Changing Trends in the Fungal Aetiology of Chronic Suppurative Otitis Media and Antifungal Susceptibility Patterns of Isolated Fungi: A Pilot Study From a Tertiary Care Centre in Central India
Introduction Middle-ear and mastoid mucosal inflammation that persists for at least six weeks with discharge is known as chronic suppurative otitis media (CSOM). It is prevalent in India, and fungal infections contribute to a notable proportion of cases. Irrational use of steroids and antibiotics is associated with increased fungal isolates. This study aims to evaluate the presence, profile, and antifungal susceptibility (AFST) of fungi in CSOM patients, using Sensititre™ YeastOne® (Thermo Fisher Scientific, Waltham, MA, USA) colorimetric broth microdilution for yeasts and disk diffusion for moulds, although bacterial causes are well established. Materials and methods This study was a one-year cross-sectional study conducted in the Department of Microbiology in collaboration with the Departments of Microbiology and ENT-Head & Neck Surgery. This one-year cross-sectional study included patients aged 12 years or older with purulent ear discharge lasting at least six weeks. Samples of middle ear exudate were gathered and prepared for mounting and culture in 10%-20% potassium hydroxide (KOH). Isolates of yeast or mould were identified at the species level using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS; Bruker Daltonics, Bremen, Germany). For the isolated yeasts, AFST was performed using the Sensititre™ YeastOne® colourimetric broth microdilution method in accordance with the CLSI M27-A3 standard, and results were interpreted according to the M60 guideline. The data were collected in an Excel sheet (Microsoft® Corp., Redmond, WA, USA), and the statistical analysis involved both descriptive and inferential techniques. Results A total of 136 clinical samples were analyzed in the study. Of these, 27 (19.9%) were KOH positive, including 12 (44.4%) that were culture negative. Overall, 30 samples (22.1%) were culture positive, of which 15 (50%) were KOH negative. The overall fungal prevalence in the study was 42 (30.9%). Among the 30 culture-positive cases, six (20%) were moulds, and 24 (80%) were yeasts. Candida albicans (n = 9) was less common than non-albicans Candida (NAC) isolates (n = 15); however, it was the most prevalent single yeast species among culture isolates (30%). Trichomonascus ciferrii and Candida auris each had four (13.3%) isolates. Candida orthopsilosis (3, 10.0%), Candida metapsilosis (2, 6.7%), and Candida tropicalis (2, 6.7%) were among the other yeasts found. Aspergillus fumigatus was the most prevalent species among mould isolates (3, 10.0%), followed by Aspergillus flavus (1, 3.3%), Aspergillus niger (1, 3.3%), and Fusarium solani (1, 3.3%). After performing AFST on yeast isolates, most isolates showed resistance to one or more antifungal drugs tested, particularly C. auris and T. ciferrii isolates. Conclusion There is currently a change in the fungal etiological pattern in CSOM patients, with increased isolation of new species, including T. ciferrii, C. auris, C. orthopsilosis, and C. metapsilosis. Identification of fungi to the species level is crucial for treatment, as many yeast species have demonstrated resistance to one or more antifungal drugs. Echinocandins and amphotericin B continue to work, but yeasts - particularly NAC species, like C. auris and T. ciferrii - often exhibit significant azole resistance.
- 23 March 2026
- Published by Springer Nature in Cureus
- Vol. 18 (3)
Open AccessChanging Trends in the Fungal Aetiology of Chronic Suppurative Otitis Media and Antifungal Susceptibility Patterns of Isolated Fungi: A Pilot Study From a Tertiary Care Centre in Central India
Introduction Middle-ear and mastoid mucosal inflammation that persists for at least six weeks with discharge is known as chronic suppurative otitis media (CSOM). It is prevalent in India, and fungal infections contribute to a notable proportion of cases. Irrational use of steroids and antibiotics is associated with increased fungal isolates. This study aims to evaluate the presence, profile, and antifungal susceptibility (AFST) of fungi in CSOM patients, using Sensititre™ YeastOne® (Thermo Fisher Scientific, Waltham, MA, USA) colorimetric broth microdilution for yeasts and disk diffusion for moulds, although bacterial causes are well established. Materials and methods This study was a one-year cross-sectional study conducted in the Department of Microbiology in collaboration with the Departments of Microbiology and ENT-Head & Neck Surgery. This one-year cross-sectional study included patients aged 12 years or older with purulent ear discharge lasting at least six weeks. Samples of middle ear exudate were gathered and prepared for mounting and culture in 10%-20% potassium hydroxide (KOH). Isolates of yeast or mould were identified at the species level using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS; Bruker Daltonics, Bremen, Germany). For the isolated yeasts, AFST was performed using the Sensititre™ YeastOne® colourimetric broth microdilution method in accordance with the CLSI M27-A3 standard, and results were interpreted according to the M60 guideline. The data were collected in an Excel sheet (Microsoft® Corp., Redmond, WA, USA), and the statistical analysis involved both descriptive and inferential techniques. Results A total of 136 clinical samples were analyzed in the study. Of these, 27 (19.9%) were KOH positive, including 12 (44.4%) that were culture negative. Overall, 30 samples (22.1%) were culture positive, of which 15 (50%) were KOH negative. The overall fungal prevalence in the study was 42 (30.9%). Among the 30 culture-positive cases, six (20%) were moulds, and 24 (80%) were yeasts. Candida albicans (n = 9) was less common than non-albicans Candida (NAC) isolates (n = 15); however, it was the most prevalent single yeast species among culture isolates (30%). Trichomonascus ciferrii and Candida auris each had four (13.3%) isolates. Candida orthopsilosis (3, 10.0%), Candida metapsilosis (2, 6.7%), and Candida tropicalis (2, 6.7%) were among the other yeasts found. Aspergillus fumigatus was the most prevalent species among mould isolates (3, 10.0%), followed by Aspergillus flavus (1, 3.3%), Aspergillus niger (1, 3.3%), and Fusarium solani (1, 3.3%). After performing AFST on yeast isolates, most isolates showed resistance to one or more antifungal drugs tested, particularly C. auris and T. ciferrii isolates. Conclusion There is currently a change in the fungal etiological pattern in CSOM patients, with increased isolation of new species, including T. ciferrii, C. auris, C. orthopsilosis, and C. metapsilosis. Identification of fungi to the species level is crucial for treatment, as many yeast species have demonstrated resistance to one or more antifungal drugs. Echinocandins and amphotericin B continue to work, but yeasts - particularly NAC species, like C. auris and T. ciferrii - often exhibit significant azole resistance.
- Open Access
- 12 October 2025
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 161, 108126
Epidemiology of non-central line-associated primary bloodstream infections in a network of Indian hospitals: A prospective surveillance study over 7 years (2017-2024)
- 12 October 2025
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 161, 108126
Open AccessEpidemiology of non-central line-associated primary bloodstream infections in a network of Indian hospitals: A prospective surveillance study over 7 years (2017-2024)
- Open Access
- 4 March 2025
- Published by IntechOpen
Advancing Fungal Diagnostic and Research Stewardship in India: A Prospective Strategic 10-Step Plan for Addressing a National Public Health Challenge
Invasive fungal infections (IFIs) are silent killers, frequently undiagnosed and untreated. India faces significant challenges with limited diagnostic facilities, scarce data on fungal infection, and rising antifungal resistance. The COVID-associated mucormycosis surge highlighted the urgent need for stronger diagnostic infrastructure for fungal infections. Recognizing this, the Indian Council of Medical Research (ICMR) launched a network of mycology laboratories with advanced diagnostic capabilities across India using a 10-step plan described in this paper. Laboratories were selected using a three-pronged screening approach. Eight Advanced Mycology Diagnostic and Research Centers (AMDRCs) were set up in North, West, Central, South, South-Central, East, and Northeast zones from 2020 to 2022. Each AMDRC received ongoing support in training and quality assurance. The network features a digital data system, fungal repository, and clinical registry to track IFIs in ICU patients. In 2022–2023, the network identified 16.3% of fungal cases, mainly Candida spp. (56%, n = 5764/10293) and Aspergillus spp. (28%, n = 2882/10293), with 1.5% (n = 227/14861) IFIs and seven rare diseases (Eumycetoma and Chromoblastomycosis) reported in 2023. Candida auris showed high resistance to Amphotericin-B (61.2%, n = 30/49) and Fluconazole (57.1%, n = 28/49). The ICMR-MycoNet has significantly improved access to fungal diagnostics, enabling early detection and management. Comprehensive data on infection trends and resistance patterns provide valuable insights for targeted treatments and outbreak preparedness, strengthening public health efforts.
- 4 March 2025
- Published by IntechOpen
Open AccessAdvancing Fungal Diagnostic and Research Stewardship in India: A Prospective Strategic 10-Step Plan for Addressing a National Public Health Challenge
Invasive fungal infections (IFIs) are silent killers, frequently undiagnosed and untreated. India faces significant challenges with limited diagnostic facilities, scarce data on fungal infection, and rising antifungal resistance. The COVID-associated mucormycosis surge highlighted the urgent need for stronger diagnostic infrastructure for fungal infections. Recognizing this, the Indian Council of Medical Research (ICMR) launched a network of mycology laboratories with advanced diagnostic capabilities across India using a 10-step plan described in this paper. Laboratories were selected using a three-pronged screening approach. Eight Advanced Mycology Diagnostic and Research Centers (AMDRCs) were set up in North, West, Central, South, South-Central, East, and Northeast zones from 2020 to 2022. Each AMDRC received ongoing support in training and quality assurance. The network features a digital data system, fungal repository, and clinical registry to track IFIs in ICU patients. In 2022–2023, the network identified 16.3% of fungal cases, mainly Candida spp. (56%, n = 5764/10293) and Aspergillus spp. (28%, n = 2882/10293), with 1.5% (n = 227/14861) IFIs and seven rare diseases (Eumycetoma and Chromoblastomycosis) reported in 2023. Candida auris showed high resistance to Amphotericin-B (61.2%, n = 30/49) and Fluconazole (57.1%, n = 28/49). The ICMR-MycoNet has significantly improved access to fungal diagnostics, enabling early detection and management. Comprehensive data on infection trends and resistance patterns provide valuable insights for targeted treatments and outbreak preparedness, strengthening public health efforts.
Candidaemia and Central Line‐Associated Candidaemia in a Network of Indian ICUs: Impact of COVID‐19 Pandemic
Background and Objectives: Candidaemia is a potentially life‐threatening emergency in the intensive care units (ICUs). Surveillance using common protocols in a large network of hospitals would give meaningful estimates of the burden of candidaemia and central line associated candidaemia in low resource settings. We undertook this study to understand the burden and epidemiology of candidaemia in multiple ICUs of India, leveraging the previously established healthcare‐associated infections (HAI) surveillance network. Our aim was also to assess the impact that the pandemic of COVID‐19 had on the rates and associated mortality of candidaemia.Methods: This study included adult patients from 67 Indian ICUs in the AIIMS‐HAI surveillance network that conducted BSI surveillance in COVID‐19 and non‐COVID‐19 ICUs during and before the COVID‐19 pandemic periods. Hospitals identified healthcare‐associated candidaemia and central line associated candidaemia and reported clinical and microbiological data to the network as per established and previously published protocols.Results: A total of 401,601 patient days and 126,051 central line days were reported during the study period. A total of 377 events of candidaemia were recorded. The overall rate of candidaemia in our network was 0.93/1000 patient days. The rate of candidaemia in COVID‐19 ICUs (2.52/1000 patient days) was significantly higher than in non‐COVID‐19 ICUs (1.05/patient days) during the pandemic period. The rate of central line associated candidaemia in COVID‐19 ICUs (4.53/1000 central line days) was also significantly higher than in non‐COVID‐19 ICUs (1.73/1000 central line days) during the pandemic period. Mortality in COVID‐19 ICUs associated with candidaemia (61%) was higher than that in non‐COVID‐19 ICUs (41%). A total of 435 Candida spp. were isolated. C. tropicalis (26.7%) was the most common species. C. auris accounted for 17.5% of all isolates and had a high mortality.Conclusion: Patients in ICUs with COVID‐19 infections have a much higher risk of candidaemia, CLAC and its associated mortality. Network level data helps in understanding the true burden of candidaemia and will help in framing infection control policies for the country.
Candidaemia and Central Line‐Associated Candidaemia in a Network of Indian ICUs: Impact of COVID‐19 Pandemic
Background and Objectives: Candidaemia is a potentially life‐threatening emergency in the intensive care units (ICUs). Surveillance using common protocols in a large network of hospitals would give meaningful estimates of the burden of candidaemia and central line associated candidaemia in low resource settings. We undertook this study to understand the burden and epidemiology of candidaemia in multiple ICUs of India, leveraging the previously established healthcare‐associated infections (HAI) surveillance network. Our aim was also to assess the impact that the pandemic of COVID‐19 had on the rates and associated mortality of candidaemia.Methods: This study included adult patients from 67 Indian ICUs in the AIIMS‐HAI surveillance network that conducted BSI surveillance in COVID‐19 and non‐COVID‐19 ICUs during and before the COVID‐19 pandemic periods. Hospitals identified healthcare‐associated candidaemia and central line associated candidaemia and reported clinical and microbiological data to the network as per established and previously published protocols.Results: A total of 401,601 patient days and 126,051 central line days were reported during the study period. A total of 377 events of candidaemia were recorded. The overall rate of candidaemia in our network was 0.93/1000 patient days. The rate of candidaemia in COVID‐19 ICUs (2.52/1000 patient days) was significantly higher than in non‐COVID‐19 ICUs (1.05/patient days) during the pandemic period. The rate of central line associated candidaemia in COVID‐19 ICUs (4.53/1000 central line days) was also significantly higher than in non‐COVID‐19 ICUs (1.73/1000 central line days) during the pandemic period. Mortality in COVID‐19 ICUs associated with candidaemia (61%) was higher than that in non‐COVID‐19 ICUs (41%). A total of 435 Candida spp. were isolated. C. tropicalis (26.7%) was the most common species. C. auris accounted for 17.5% of all isolates and had a high mortality.Conclusion: Patients in ICUs with COVID‐19 infections have a much higher risk of candidaemia, CLAC and its associated mortality. Network level data helps in understanding the true burden of candidaemia and will help in framing infection control policies for the country.
- Open Access
- 3 June 2024
- Published by Scientific Scholar in Journal of Laboratory Physicians
- p. 1-8
Experience of rigorous practice of antimicrobial stewardship program and its impact on antibiotic consumption
Objectives: Antimicrobial resistance (AMR) is the next pandemic with a huge global economic burden. A customized antimicrobial stewardship program (AMSP) is a well-recognized tool for containment of AMR. The current study was undertaken to identify the impact of AMSP measures on the trends of antibiotic consumption rates, e.g., defined daily dose (DDD) and days of therapy (DOT) per 100 patient days in pre-identified areas of the hospital. Materials and Methods: The present study was a case-record-based extended cross-sectional study carried out in a tertiary care institute in central India from January 2021 to September 2021. Time-bound feasible sampling was undertaken, and all cases were included without any exclusion criteria. The study was approved by the Ethics Committee of the Institute and funded by the Indian Council of Medical Research (ICMR). Statistical Analysis: The data was entered into a spreadsheet. The calculation of DDD and DOT was performed individually for each antibiotic as per WHO tool per 100 patient days. Results: In high-priority areas such as intensive care unit and high dependency unit, the top three DDD/100 days were meropenem (77.9), colistin (41.4), and piperacillin-tazobactam (13.5) versus the top 3 DOT/100 patient days were meropenem (40.5), colistin (20.9), and piperacillin-tazobactam (15.7). In low-priority areas such as general wards, the top 3 DDD/100 patient days were meropenem (45.4), piperacillin-tazobactam (22.6), and cefoperazone (5.0) versus the top three DOT/100 patient days were meropenem (45.4), cefoperazone (44.9), and piperacillintazobactam (22.6). There was a downward trend of consumption of almost all these antibiotics when measured at baseline and the next two quarters. DDD and DOT per 100 patient days had a positive linear correlation during the study period. Conclusions: The present study demonstrates about 50% reduction in consumption of ICMR priority antibiotics with a yearlong AMSP. DDD and DOT per 100 patient days can be calculated with minimal effort, even in extremely busy hospitals. DOT tools are less labor-intensive and, hence, should be the pivotal tool for antibiotic exposure measurement.
- 3 June 2024
- Published by Scientific Scholar in Journal of Laboratory Physicians
- p. 1-8
Open AccessExperience of rigorous practice of antimicrobial stewardship program and its impact on antibiotic consumption
Objectives: Antimicrobial resistance (AMR) is the next pandemic with a huge global economic burden. A customized antimicrobial stewardship program (AMSP) is a well-recognized tool for containment of AMR. The current study was undertaken to identify the impact of AMSP measures on the trends of antibiotic consumption rates, e.g., defined daily dose (DDD) and days of therapy (DOT) per 100 patient days in pre-identified areas of the hospital. Materials and Methods: The present study was a case-record-based extended cross-sectional study carried out in a tertiary care institute in central India from January 2021 to September 2021. Time-bound feasible sampling was undertaken, and all cases were included without any exclusion criteria. The study was approved by the Ethics Committee of the Institute and funded by the Indian Council of Medical Research (ICMR). Statistical Analysis: The data was entered into a spreadsheet. The calculation of DDD and DOT was performed individually for each antibiotic as per WHO tool per 100 patient days. Results: In high-priority areas such as intensive care unit and high dependency unit, the top three DDD/100 days were meropenem (77.9), colistin (41.4), and piperacillin-tazobactam (13.5) versus the top 3 DOT/100 patient days were meropenem (40.5), colistin (20.9), and piperacillin-tazobactam (15.7). In low-priority areas such as general wards, the top 3 DDD/100 patient days were meropenem (45.4), piperacillin-tazobactam (22.6), and cefoperazone (5.0) versus the top three DOT/100 patient days were meropenem (45.4), cefoperazone (44.9), and piperacillintazobactam (22.6). There was a downward trend of consumption of almost all these antibiotics when measured at baseline and the next two quarters. DDD and DOT per 100 patient days had a positive linear correlation during the study period. Conclusions: The present study demonstrates about 50% reduction in consumption of ICMR priority antibiotics with a yearlong AMSP. DDD and DOT per 100 patient days can be calculated with minimal effort, even in extremely busy hospitals. DOT tools are less labor-intensive and, hence, should be the pivotal tool for antibiotic exposure measurement.
- Open Access
- 16 April 2024
- Published by Springer Nature in Cureus
- Vol. 16 (4) , e58413
The Burden of Protozoal and Helminth Intestinal Infections and Related Risk Factors Among the Households of Migrant Construction Workers in Bhopal
There are a few existing gaps and paucity of literature from Southeast Asia on the prevalence of intestinal parasitic infections among migrant construction workers. The present cross-sectional study was conducted to address this gap among migrant construction workers and their households in Bhopal. The study design included an interview questionnaire survey prior to the enrollment of participants and stool sample collection. The stool samples were processed according to the study protocol of macroscopy, occult blood testing, microscopy techniques combined with modified acid-fast, and sedimentation techniques. Participants were deemed positive if they exhibited microscopic findings in one out of three stool samples per recruit. We recommended clinical consultation for these cases and provided a report. Direct therapeutic intervention was not part of the study. The total recruits were 361. The predominant age group was young, i.e., aged 21 to 30 years (122/361, 33.8%), with the majority of females (55.2%). Most workers were occupied with work of digging soil (47.4%). The majority of participants (93.1%) practiced open field defecation (OFD). The prevalence of intestinal parasitic infections among migrant workers and households was 36.9% (133/361). Monoinfection was 88.7%, with 41% from Entamoeba histolytica/Entamoeba dispar. Monoinfection with Hymenolepis nana (10.2%) was a predominant helminth. The most common coinfection observed was of Giardia intestinalis with Ancylostoma duodenale (26.7%). Hand washing was the only independent predictor with an odds ratio of 3.6. Migrant behavior of the construction workers and their households was the major reason for not reaching the benefits of deworming schemes for children and vulnerability to intestinal parasitic infections.
- 16 April 2024
- Published by Springer Nature in Cureus
- Vol. 16 (4) , e58413
Open AccessThe Burden of Protozoal and Helminth Intestinal Infections and Related Risk Factors Among the Households of Migrant Construction Workers in Bhopal
There are a few existing gaps and paucity of literature from Southeast Asia on the prevalence of intestinal parasitic infections among migrant construction workers. The present cross-sectional study was conducted to address this gap among migrant construction workers and their households in Bhopal. The study design included an interview questionnaire survey prior to the enrollment of participants and stool sample collection. The stool samples were processed according to the study protocol of macroscopy, occult blood testing, microscopy techniques combined with modified acid-fast, and sedimentation techniques. Participants were deemed positive if they exhibited microscopic findings in one out of three stool samples per recruit. We recommended clinical consultation for these cases and provided a report. Direct therapeutic intervention was not part of the study. The total recruits were 361. The predominant age group was young, i.e., aged 21 to 30 years (122/361, 33.8%), with the majority of females (55.2%). Most workers were occupied with work of digging soil (47.4%). The majority of participants (93.1%) practiced open field defecation (OFD). The prevalence of intestinal parasitic infections among migrant workers and households was 36.9% (133/361). Monoinfection was 88.7%, with 41% from Entamoeba histolytica/Entamoeba dispar. Monoinfection with Hymenolepis nana (10.2%) was a predominant helminth. The most common coinfection observed was of Giardia intestinalis with Ancylostoma duodenale (26.7%). Hand washing was the only independent predictor with an odds ratio of 3.6. Migrant behavior of the construction workers and their households was the major reason for not reaching the benefits of deworming schemes for children and vulnerability to intestinal parasitic infections.
- Open Access
- 20 March 2024
- Published by Elsevier in Medical Mycology Case Reports
- Vol. 44, 100644
Traumatic implantation keratitis caused by Schizophyllum commune in Central India
- 20 March 2024
- Published by Elsevier in Medical Mycology Case Reports
- Vol. 44, 100644
Open AccessTraumatic implantation keratitis caused by Schizophyllum commune in Central India
- Open Access
- 16 February 2024
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 13 (1) , e54672
Pan-Indian Clinical Registry of Invasive Fungal Infections Among Patients in the Intensive Care Unit: Protocol for a Multicentric Prospective Study
Background: Fungal infections are now a great public health threat, especially in those with underlying risk factors such as neutropenia, diabetes, high-dose steroid treatment, cancer chemotherapy, prolonged intensive care unit stay, and so on, which can lead to mycoses with higher mortality rates. The rates of these infections have been steadily increasing over the past 2 decades due to the increasing population of patients who are immunocompromised. However, the data regarding the exact burden of such infection are still not available from India. Therefore, this registry was initiated to collate systematic data on invasive fungal infections (IFIs) across the country. Objective: The primary aim of this study is to create a multicenter digital clinical registry and monitor trends of IFIs and emerging fungal diseases, as well as early signals of any potential fungal outbreak in any region. The registry will also capture information on the antifungal resistance patterns and the contribution of fungal infections on overall morbidity and inpatient mortality across various conditions. Methods: This multicenter, prospective, noninterventional observational study will be conducted by the Indian Council of Medical Research through a web-based data collection method from 8 Advanced Mycology Diagnostic and Research Centers across the country. Data on age, gender, clinical signs and symptoms, date of admission, date of discharge or death, diagnostic tests performed, identified pathogen details, antifungal susceptibility testing, outcome, and so on will be obtained from hospital records. Descriptive and multivariate statistical methods will be applied to investigate clinical manifestations, risk variables, and treatment outcomes. Results: These Advanced Mycology Diagnostic and Research Centers are expected to find the hidden cases of fungal infections in the intensive care unit setting. The study will facilitate the enhancement of the precision of fungal infection diagnosis and prompt treatment modalities in response to antifungal drug sensitivity tests. This registry will improve our understanding of IFIs, support evidence-based clinical decision-making ability, and encourage public health policies and actions. Conclusions: Fungal diseases are a neglected public health problem. Fewer diagnostic facilities, scanty published data, and increased vulnerable patient groups make the situation worse. This is the first systematic clinical registry of IFIs in India. Data generated from this registry will increase our understanding related to the diagnosis, treatment, and prevention of fungal diseases in India by addressing pertinent gaps in mycology. This initiative will ensure a visible impact on public health in the country.
- 16 February 2024
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 13 (1) , e54672
Open AccessPan-Indian Clinical Registry of Invasive Fungal Infections Among Patients in the Intensive Care Unit: Protocol for a Multicentric Prospective Study
Background: Fungal infections are now a great public health threat, especially in those with underlying risk factors such as neutropenia, diabetes, high-dose steroid treatment, cancer chemotherapy, prolonged intensive care unit stay, and so on, which can lead to mycoses with higher mortality rates. The rates of these infections have been steadily increasing over the past 2 decades due to the increasing population of patients who are immunocompromised. However, the data regarding the exact burden of such infection are still not available from India. Therefore, this registry was initiated to collate systematic data on invasive fungal infections (IFIs) across the country. Objective: The primary aim of this study is to create a multicenter digital clinical registry and monitor trends of IFIs and emerging fungal diseases, as well as early signals of any potential fungal outbreak in any region. The registry will also capture information on the antifungal resistance patterns and the contribution of fungal infections on overall morbidity and inpatient mortality across various conditions. Methods: This multicenter, prospective, noninterventional observational study will be conducted by the Indian Council of Medical Research through a web-based data collection method from 8 Advanced Mycology Diagnostic and Research Centers across the country. Data on age, gender, clinical signs and symptoms, date of admission, date of discharge or death, diagnostic tests performed, identified pathogen details, antifungal susceptibility testing, outcome, and so on will be obtained from hospital records. Descriptive and multivariate statistical methods will be applied to investigate clinical manifestations, risk variables, and treatment outcomes. Results: These Advanced Mycology Diagnostic and Research Centers are expected to find the hidden cases of fungal infections in the intensive care unit setting. The study will facilitate the enhancement of the precision of fungal infection diagnosis and prompt treatment modalities in response to antifungal drug sensitivity tests. This registry will improve our understanding of IFIs, support evidence-based clinical decision-making ability, and encourage public health policies and actions. Conclusions: Fungal diseases are a neglected public health problem. Fewer diagnostic facilities, scanty published data, and increased vulnerable patient groups make the situation worse. This is the first systematic clinical registry of IFIs in India. Data generated from this registry will increase our understanding related to the diagnosis, treatment, and prevention of fungal diseases in India by addressing pertinent gaps in mycology. This initiative will ensure a visible impact on public health in the country.
- Open Access
- 5 January 2024
- Published by MDPI AG in Journal of Fungi
- Vol. 10 (1) , 42
The Development of a Clinical Registry Digital Database on Invasive Fungal Infections in India: Advancing Epidemiological Understanding and Patient Care
A well-structured digital database is essential for any national priority project as it can provide real-time data analysis and facilitate quick decision making. In recent times, particularly after the COVID-19 pandemic, invasive fungal infections (IFIs) have emerged as a significant public health challenge in India, affecting vulnerable population, including immunocompromised individuals. The lack of comprehensive and well-structured data on IFIs has hindered efforts to understand their true burden and optimize patient care. To address this critical knowledge gap, the ICMR has undertaken a Pan-India pioneer initiative to develop a network of Advanced Mycology Diagnostic research centres in different geographical zones of the country (ICMR-MycoNet). Under the aegis of this project, a clinical registry on IFIs in the ICUs is initiated. This process paper presents a detailed account of the steps involved in the establishment of a web-based data entering and monitoring platform to capture data electronically, ensuring robust and secure data collection and management. This system not only allows participating ICMR-MycoNet centres to enter patient information directly into the database using standardized Case Report Form (CRF) but also includes data validation checks to ensure the accuracy and completeness of entered data. It is complemented by a real-time, web-based, and adaptable data visualization platform. This registry aims to provide crucial epidemiological insights, promote evidence-based hospital infection control programs, and ultimately improve patient outcomes in the face of this formidable healthcare challenge.
- 5 January 2024
- Published by MDPI AG in Journal of Fungi
- Vol. 10 (1) , 42
Open AccessThe Development of a Clinical Registry Digital Database on Invasive Fungal Infections in India: Advancing Epidemiological Understanding and Patient Care
A well-structured digital database is essential for any national priority project as it can provide real-time data analysis and facilitate quick decision making. In recent times, particularly after the COVID-19 pandemic, invasive fungal infections (IFIs) have emerged as a significant public health challenge in India, affecting vulnerable population, including immunocompromised individuals. The lack of comprehensive and well-structured data on IFIs has hindered efforts to understand their true burden and optimize patient care. To address this critical knowledge gap, the ICMR has undertaken a Pan-India pioneer initiative to develop a network of Advanced Mycology Diagnostic research centres in different geographical zones of the country (ICMR-MycoNet). Under the aegis of this project, a clinical registry on IFIs in the ICUs is initiated. This process paper presents a detailed account of the steps involved in the establishment of a web-based data entering and monitoring platform to capture data electronically, ensuring robust and secure data collection and management. This system not only allows participating ICMR-MycoNet centres to enter patient information directly into the database using standardized Case Report Form (CRF) but also includes data validation checks to ensure the accuracy and completeness of entered data. It is complemented by a real-time, web-based, and adaptable data visualization platform. This registry aims to provide crucial epidemiological insights, promote evidence-based hospital infection control programs, and ultimately improve patient outcomes in the face of this formidable healthcare challenge.
- Open Access
- 29 December 2023
- Published by MDPI AG in Preprints.org
Prevalence of Intestinal Parasitic Infections and Associated Risk Factors Among the Households of Migrant Construction Workers at Bhopal
Intestinal Parasitic infections are one of the most common infections in tropics. There is paucity of data on prevalence of intestinal parasite infections among migrant construction workers and their house holds so this study was taken up. A cross sectional study was conducted for eight months with an aim to determine the prevalence and assess the associated risk factors among the households of migrant construction workers at AIIMS Bhopal. A semi-structured interview questionnaire survey was conducted prior to collection of stool samples. Each stool sample was examined macroscopically followed by occult blood testing. Wet mount observation was followed by modified acid fast staining and formal ether sedimentation. Recruits with pathogenic parasites in any of the three samples were considered positive and treated as per the national guidelines for age, drug and dose by clinical consultation. 361 participants were recruited. 122/361 (33.8%) were between 21 to 30 years. 55.2% females, 47.4% had occupation of digging soil, 93.1% practiced open field defecation. 36.9% (133/361) was the prevalence of intestinal parasitic infection. 88.7% monoinfection, E.histolytica/dispar (41%) and H.nana( 10.2%) were most prevalent parasites. 26.7%) was commonest. 11.28%coinfection, G. intestinalis with A. duodenale (26.7%) was commonest. In our study only hand washing was independent predictor having Odds Ratio of 3.6 with confidence interval 1.00-13.00(those who don’t wash hands before meals are 3.6 times more likely to develop infection). Only few studies address migrant construction workers, their nomadic behaviour makes them vulnerable for intestinal parasitic infections and not benefitting from prevention programmes as deworming programme.
- 29 December 2023
- Published by MDPI AG in Preprints.org
Open AccessPrevalence of Intestinal Parasitic Infections and Associated Risk Factors Among the Households of Migrant Construction Workers at Bhopal
Intestinal Parasitic infections are one of the most common infections in tropics. There is paucity of data on prevalence of intestinal parasite infections among migrant construction workers and their house holds so this study was taken up. A cross sectional study was conducted for eight months with an aim to determine the prevalence and assess the associated risk factors among the households of migrant construction workers at AIIMS Bhopal. A semi-structured interview questionnaire survey was conducted prior to collection of stool samples. Each stool sample was examined macroscopically followed by occult blood testing. Wet mount observation was followed by modified acid fast staining and formal ether sedimentation. Recruits with pathogenic parasites in any of the three samples were considered positive and treated as per the national guidelines for age, drug and dose by clinical consultation. 361 participants were recruited. 122/361 (33.8%) were between 21 to 30 years. 55.2% females, 47.4% had occupation of digging soil, 93.1% practiced open field defecation. 36.9% (133/361) was the prevalence of intestinal parasitic infection. 88.7% monoinfection, E.histolytica/dispar (41%) and H.nana( 10.2%) were most prevalent parasites. 26.7%) was commonest. 11.28%coinfection, G. intestinalis with A. duodenale (26.7%) was commonest. In our study only hand washing was independent predictor having Odds Ratio of 3.6 with confidence interval 1.00-13.00(those who don’t wash hands before meals are 3.6 times more likely to develop infection). Only few studies address migrant construction workers, their nomadic behaviour makes them vulnerable for intestinal parasitic infections and not benefitting from prevention programmes as deworming programme.